MedTrace Logo

Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions

NCT00676455 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2013-05-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the ability of a new type of CT computer program(MeVis™)to accurately analyze and measure the size and changes in metastatic Liver and Lung tumors. This study will evaluate the data from current CT evaluation methods using the MeVis™ 3-D software.

Conditions

Sponsors & Collaborators

  • Lahey Clinic

    lead OTHER

Principal Investigators

  • Christoph Wald, M.D., Ph.D · Lahey Clinic, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00676455 on ClinicalTrials.gov